Inventor
Deborah Ann Rathjen
Inventor
New South Wales, AU
Overview
Patents· 24 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes39%
C07KPeptides29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
Y02ATechnologies for adaptation to climate change8%
C12NMicroorganisms or enzymes5%
C07CAcyclic or carbocyclic compounds3%
PatentTitleYear
8,052,982'Bioimplant formulation comprising lecithin and stearin'20117,605,233'Tumour necrosis factor binding ligands'20097,553,641'Tumour necrosis factor binding ligands'20097,544,782'Tumour necrosis factor binding ligands'20097,528,237'Tumour necrosis factor binding ligands'20097,517,963'Tumour necrosis factor binding ligands'20096,913,761'Bioimplant formulation'20056,593,458'Tumor necrosis factor peptide binding antibodies'20036,498,237'Tumor necrosis factor antibodies'20026,451,983'Tumor necrosis factor antibodies'20026,448,380'Tumor necrosis factor antibodies'20026,416,757'Tumor necrosis factor antibodies'20026,375,928'Neutrophil stimulating peptides'20026,376,688'Modified polyunsaturated fatty acids'20026,265,374'Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis'20016,262,119'Methods of treating immunopathologies using polyunsaturated fatty acids'20016,011,014'Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis'20005,998,476'Synthetic polyunsaturated fatty acid analogues'19995,959,087'Tumour necrosis factor binding ligands'19995,795,859'Peptide which abrogates TNF and/or LPS toxicity'19985,767,156'Polyunsaturated fatty acids and uses thereof'19985,756,449'Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease'19985,644,034'Tumour necrosis factor binding ligands'19975,587,457'Neutrophil stimulating peptides'1996Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1996–2002Patents assigned to PEPTIDE TECHNOLOGY LTD (10)· patent assignee history
1996–2005Based in Thornleigh, AU· patent location history
1997–2003Based in New South Wales, AU· patent location history
1998–2002Based in Sheidow Park, AU· patent location history
1998Based in Sydney, AU· patent location history
2001–2002Patents assigned to WOMENS & CHILDRENS HOSPITAL (2)· patent assignee history
2001Patents assigned to ADVANCED IMMUNI T INC (1)· patent assignee history
2002–2005Patents assigned to PEPTECH LTD (6)· patent assignee history
2009Patents assigned to ARANA THERAPEUTICS LTD (5)· patent assignee history
2009–2011Based in Flagstaff Hill, AU· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PEPTIDE TECHNOLOGY LTD | 10 | 1996–2002 |
| PEPTECH LTD | 6 | 2002–2005 |
| ARANA THERAPEUTICS LTD | 5 | 2009 |
| WOMENS & CHILDRENS HOSPITAL | 2 | 2001–2002 |
| ADVANCED IMMUNI T INC | 1 | 2001 |
Locations
| Location | Patents | Span |
|---|---|---|
| New South Wales, AU | 10 | 1997–2003 |
| Flagstaff Hill, AU | 6 | 2009–2011 |
| Sheidow Park, AU | 4 | 1998–2002 |
| Thornleigh, AU | 3 | 1996–2005 |
| Sydney, AU | 1 | 1998 |